Company news
Currenc Group Inc. news in 2020
Currenc Group Inc.'s news releases, calls and decks from 2020, newest first.
CURE Pharmaceutical to Present at LD Micro on December 15, Schedules Investor Video Webcast for December 17
December 13, 2020
Nicole Kidman Partners With Sera Labs A CURE Pharmaceutical Company As A Strategic Business Partner And Global Brand Ambassador
December 9, 2020
Nicole Kidman Partners With SeraLabs, a CURE Pharmaceutical Company, as a Strategic Business Partner and Global Brand Ambassador
December 7, 2020
CURE Pharmaceutical Issues Letter to Shareholders
November 17, 2020
CURE Pharmaceutical Closes $10 Million Financing
November 1, 2020
CURE Pharmaceutical’s® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology
October 28, 2020
CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company
September 23, 2020
CURE Pharmaceutical to Present at Two Virtual Events in September
September 1, 2020
Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, to be acquired by CURE Pharmaceutical in a $20 Million Transaction
July 29, 2020
CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
July 27, 2020
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 14, 2020
CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements
July 7, 2020
CURE Pharmaceutical Appoints Chief Business Officer
June 15, 2020
CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition
June 8, 2020
CURE Pharmaceutical [OTCQB: CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
June 2, 2020
CURE Pharmaceutical [OTCQB: CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
April 20, 2020
CURE Pharmaceutical [OTCQB: CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific
February 11, 2020
UPDATE – CURE Pharmaceutical [OTCQB: CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
February 4, 2020
CURE Pharmaceutical [OTCQB: CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
February 4, 2020